Trial Information

Summary: Molecular Pathogenesis of Acute Leukemia and Myelodysplasia

You have been asked to participate in this research study because you have previously untreated or relapsed acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) or primary (non-treatment related) myelodysplastic syndrome.  The purpose of this study is to understand how acute leukemias and myelodysplasia develop.  These studies may help researchers understand how these malignancies develop and help develop new treatments for these disorders. Your participation in this study is for a one-time collection of bone marrow or blood sample.  Information regarding your disease status will be collected from your medical records for a period of up to 5 years. 

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: December 1, 2008 at 3:15:42 PM